MedQuist Holdings Inc. (Nasdaq:MEDH), a leading provider of integrated clinical documentation solutions for the U.S. healthcare system, today announced that it has been awarded a contract by Aspirus Inc., of Wausau, Wisconsin, for clinical documentation technology. The offering includes mobility enabled solutions, digital voice capture, a speech recognition and document workflow platform, voice-enabled EHR functionality and transcription services.

In preparation for Computerized Physician Order Entry (CPOE), the Aspirus team needed to replace their aging voice capture and transcription platform, according to Jerry Mourey, chief information officer (CIO) for Aspirus. In addition, Aspirus HIM leaders wanted leading-edge speech recognition technology to help them improve productivity of their in-house transcriptionists while boosting physician adoption and usability of their EHR. Cost reduction and improved reimbursements were also goals of the organization.

"We considered an upgrade based on our longstanding relationship, our deep functional and technical knowledge and a limited amount of time and resources for exploring other options – until we discovered the exceptional portfolio of MedQuist solutions and the team that stands behind them," Mourey added. "Making time for due diligence, we realized MedQuist could do more for us in terms of technology, customer care and meeting outcomes to support our needs, goals and objectives."

After a six-month evaluation period, Aspirus selected MedQuist and its DocQment™ EP platform. Aspirus' EHR training team was also impressed by the five-minute installation and simple support features for DocQment Direct, which provides EHR speech recognition capabilities.

"MedQuist proved – even to our most hesitant clinicians – that upgrading to a robust enterprise technology platform would not only be seamless for them, but that they will realize significant time savings from user-friendly tools that streamline workflow, deliver highly accurate speech recognition that follows physicians wherever they go and interface beautifully," said Dr. Larry Gordon, D.O., Medical Director of Informatics."Whether we want to document with a smart phone, dictate straight into the EHR or edit our own reports in a real-time, interactive environment, MedQuist has the technology and the know-how to make it a reality and make our jobs easier."

MedQuist speech recognition and workflow platforms are designed to increase MT productivity and facilitate impressive turnaround time improvements. With MedQuist, Aspirus plans to complete critical ED work more quickly, reduce discharge summaries from 72 hours to less than 24 hours, and reduce cardiology reports from 24 hours to less than 12 hours. "Faster report turnaround times (TATs) speed coding, billing and patient movement – enabling rapid care delivery for patients and a healthier revenue cycle for the hospital," said Jeanne Scinto, PhD, MPH, vice president Corporate Quality Services for Aspirus.

"Improved efficiency and productivity is just the beginning of the ROI we will experience by implementing MedQuist technology. MedQuist also offered a better way for us to manage our capital dollars by moving from enterprise licenses to transactional licenses. Their cloud-based technology minimizes maintenance costs, and integration with our EHR and billing systems means better reimbursements," said Chris Plaisance, director of IT Solutions for Aspirus. "We will realize immediate cost reduction benefits, and over the next five years we expect to see savings of $6 million or more."

MedQuist's industry-specific expertise, genuine understanding of Aspirus' unique needs and challenges, and ability to demonstrate success, long-term support and exceptional reliability led to the partnership, according to Peter Masanotti, president and chief executive officer (CEO) of MedQuist. "We are honored to be selected by Aspirus as their partner of choice," he said.

About MedQuist

MedQuist is a leading provider of medical transcription services and a leader in technology-enabled clinical documentation workflow. MedQuist's enterprise solutions – including mobile voice capture devices, speech recognition, Web-based workflow platforms, and global network of medical editors – help healthcare facilities improve patient care, increase physician satisfaction, and lower operational costs. For more information, please visit www.medquist.com.

About Aspirus

Aspirus is a non-profit, community-directed health system based in Wausau. With more than 5,500 employees, Aspirus serves people in 14 Wisconsin counties and the Upper Peninsula of Michigan through a series of affiliated hospitals; home health care; pharmacies; hospice care; critical care and helicopter transport service; a durable medical goods company; a nursing home; a large volunteer corps; an affiliated physician network; a philanthropic and research foundation; and an extensive clinics network.

"Safe Harbor" Statement under the U.S. Private Securities Litigation Reform Act of 1995: Statements in this press release regarding MedQuist's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. Actual outcomes and results may differ materially from what is expressed or forecasted in forward-looking statements. As a result, forward-looking statements speak only as of the date they were made, and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

CONTACT: Thomas Mitchell
         Director of Marketing
         615-798-6630
         tmitchell@medquist.com
Medx (CE) (USOTC:MEDH)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Medx (CE) Charts.
Medx (CE) (USOTC:MEDH)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Medx (CE) Charts.